Company Overview and News

 
Gujarat State Petronet Limited - Shareholders meeting

2018-09-29 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GSPL 532702

 
Broker's call: GSPL (Buy)

2018-09-28 thehindubusinessline
Petroleum and Natural Gas Regulatory Board (PNGRB) has approved a revised tariff for both high pressure (HP) and low pressure (LP) gas transportation pipelines of Gujarat State Petronet Ltd (GSPL). For the HP gas grid, the tariff has been revised by 11 per cent for the period up to FY18. Additionally, from FY19, the tariff has been increased by 42 per cent.
GSPL 532702

 
Gujarat State Petronet, GAIL stocks spurt

2018-09-28 thehindubusinessline
Shares of Gujarat State Petronet, and GAIL (India) jumped on tariff hike. Gujarat State Petronet Ltd, and GAIL (India) Ltd rose 4.05 per cent and 6.35 per cent, respectively.
GSPL 532702

 
Gail India, GSPL gain 3-7% as PNGRB revises tariffs for key gas transportation pipelines

2018-09-28 moneycontrol
Shares of Gail India and Gujarat State Petronet (GSPL) gained 3-7 percent intraday Friday after Petroleum and Natural Gas Regulatory Board (PNGRB) revised tariffs for key gas transportation pipelines.
GAILY LSE GAILF GSPL 532702

 
An evening walk down Dalal Street | Financials weigh big on Sensex, Nifty in September; midcaps correct

2018-09-28 moneycontrol
Over 2,000-point fall on the Sensex, while 700-pt decline on the Nifty. This sums up how the market performed in September, reflecting the pain investors went through. On Friday, benchmarks continued with its negative streak, with the Nifty ending the first day of October series below 11,000-mark.
YESBANK AXB 500228 GSPL 532648 532702 YYBKY JSWSTEEL 532215 AXBKY 500182 AXBA AXISBANK GAILY HEROMOTOCO GAILF HRTQY

 
Little room to cut oil stocks to tackle crude spike: IOC

2018-09-27 freepressjournal.in
New Delhi : Indian Oil Corporation (IOC), the country’s largest refiner, doesn’t see much room for cutting oil inventories to deal with the double whammy of a jump in global oil prices and weakness in the rupee, the company’s Director (Refineries) BV Rama Gopal said on Wednesday.
IOC ANNRY ADANIENT GSPL 530965 532702 512599

 
Gujarat State Petronet Limited - AGM/Book Closure

2018-08-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GSPL 532702

 
Gujarat State Petronet Limited - Shareholders meeting

2018-08-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GSPL 532702

 
Gujarat State Petronet Limited - Updates

2018-08-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GSPL 532702

 
Gujarat State Petronet Limited - Appointment

2018-08-28 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GSPL 532702

 
ONGC in talks to buy five GSPC blocks

2018-08-16 livemint
Mumbai: The country’s largest oil exploration and production company, Oil and Natural Gas Corp. Ltd (ONGC), is in talks to buy five blocks from the Gujarat State Petroleum Corp. Ltd (GSPC), according to two people aware of the development.
GUJGAS 539336 GSPL 532702

 
Petronet LNG: Strong volumes drive growth in Q1, buy for the long term

2018-07-31 moneycontrol
Petronet LNG (PLNG) reported a healthy set of Q1 numbers, with a 42 percent year-on-year (YoY) increase in revenue, led by higher volumes at the Dahej terminal due to increased downstream demand and closure of Dabhol terminal on account of the monsoon. Earnings before interest, tax, depreciation, and amortisation (EBITDA) grew 26 percent YoY. The company was able to usher in substantial reduction in interest cost and other expenses sequentially.
PQRTY GSPL 532702 PETRONET SZHFF 532522

 
Oilex, GSPC spar over ownership of Cambay block

2018-07-31 livemint
Mumbai/Ahmedabad: Australia-based Oilex Ltd has issued a notice to Gujarat State Petroleum Corp. (GSPC) asking it to surrender its controlling stake in the Cambay basin block where both companies are partners. Oilex had in a notice issued on 29 May, 2018, warned GSPC to settle the outstanding dues within 60 days, failing which it would be deemed that GSPC had transferred all its participating interest in the production sharing contract (PSC) to Oilex.
GUJGAS 539336 GSPL 532702

 
Gujarat State Petronet Limited - Financial Result Updates

2018-07-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GSPL 532702

 
Gujarat State Petronet Limited - Resignation

2018-07-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
GSPL 532702

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...